Purchase Order HHSN272201500875P
- Not listed
- This is a $15,395.83 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for TruSeq reagent kits. The award has no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has previously received prime contracts and subcontracts from federal agencies like NIH, CDC, USDA, and VA to provide a range of sequencing...
- This is a $7,362.19 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the TRUSEQ SBS KIT V3. The award has no set-aside designation. Illumina is a manufacturer of sequencing and array-based genomic analysis instruments and reagents, and has provided a range of sequencing systems, reagents, and related products to support research and diagnostics across various...
- This is a $11,439.25 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Illumina, Inc. for ILLUMINA TRUSEQ REAGENT KITS. The award has no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, has previously received prime federal contracts and sub-awards from agencies like the NIH, CDC, USDA, and VA to support their genomic sequencing and analysis...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of TruSeq sequencing kits. The contract, valued at $12,697.30, has no set-aside designation and is for the ultimate completion of the order by September 5, 2014. Illumina, a manufacturer of sequencing and array-based genomic analysis instruments and reagents, has a history of providing...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of Illumina biomedical sequencing instruments and related materials. The $7,998.65 contract is for the purchase of Illumina's sequencing systems, reagents, and consumables to support genomic research and diagnostics. Illumina is a leading manufacturer of genetic analysis...
- This firm-fixed-price delivery order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $14,995.63 contract is for the provision of Illumina's TruSeq brand sequencing kits, to be performed in San Diego, California. The award has no set-aside designation. Illumina has previously received prime contracts from various federal agencies, including...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of TruSeq sequencing kits. The order, valued at $8,623.90, does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the National Institutes of Health,...
- This firm fixed-price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency within the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $8,366.17 award is for the procurement of Illumina's TruSeq DNA Sample Prep Kit Set A, which supports sample preparation for genomic sequencing. Illumina has a history of prime federal contract and subcontract...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The $24,595.46 award is for the provision of Illumina's TruSeq sequencing kits. Illumina has previously received prime federal contracts from agencies such as the NIH, CDC, USDA, and VA to provide a range of its...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian federal agency. The order is for Illumina reagent kits, with a ceiling value of $10,498.14 and a period of performance through September 2, 2025. Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, is the prime contractor. There is no set-aside designation for this...
This $7,831.40 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Illumina, Inc. for the provision of TruSeq Rapid Kits and Buffers. Illumina is a manufacturer of genetic sequencing instruments and reagents, and has been awarded numerous prior prime contracts and subcontracts by government agencies to support nucleic acid sequencing and analysis capabilities. This contract does not have a set-aside designation. Illumina has also been issued an Indefinite Delivery Contract worth up to $3.3 million by the Department of the Navy Bureau of Medicine and Surgery to provide reagents and controls for their biological threat characterization work.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 7/2/15 |